As I Read the op-ed piece “Does a Drug Firm's Free Lunch Influence Doctors?” (Boston Globe, May 18), I thought, how unusual — this writer actually seems to have a positive attitude about pharmaceutical industry/physician relationships. The piece...
The Senate Finance Committee report on CME, combined with extensive media coverage about the inappropriate relationships between doctors and the pharmaceutical industry, including The New England Journal of Medicine article “A National Survey of...
In South Florida, Fontaine-bleau Miami Beach is undergoing a massive $1 billion renovation and expansion. It has joined Associated Luxury Hotels International, which will provide national sales services. Its oceanfront suites tower now offers 462...
These are not the Best of times for the pharmaceutical industry. More regulations, increased federal scrutiny, pricing pressures, and a tarnished public image all cloud the present — and future — of the industry. But along with these challenges...
Approximately 40 senior planners from more than 20 pharmaceutical companies conducted a closed-door summit, facilitated by Barbara Taylor Carpender, CMM, Chief Alliance Officer, Taylored Alliances, Denver, during the first morning of the Third...